Glucotrack amends warrant for Nasdaq compliance
Glucotrack amended a warrant to include a 20% floor price for share purchases relative to Nasdaq requirements. This change aims to protect the holder against excessive reductions to the exercise price.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed